The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.

Rani Therapeutics Holdings Inc (NASDAQ:RANI) experienced an 18% jump in its stock price following news that the ...

In a quiet corner of Glasgow’s East End, a radical public health experiment is underway. For the first time in the United Kingdom, people who inject illicit drugs such as heroin and cocaine can do so ...

Britons taking GLP-1 weight loss injections could face the unwanted side effect of 'Ozempic face' - a phenomenon causing ...

Lenacapavir, the first FDA-approved, twice-yearly injectable PrEP for HIV prevention, shows 96% efficacy and offers ...

GSK has concluded the acquisition of efimosfermin alfa, an investigational therapeutic for serious liver disease, from Boston Pharmaceuticals ...